HCA Healthcare Inc. (HCA)
HCA Healthcare to Acquire CHCP to Strengthen Workforce Development
HCA plans to acquire CHCP, expanding healthcare education efforts and boosting its pipeline of trained professionals across hospitals and care sites.
HCA Healthcare, Inc. (HCA) Presents at RBC Capital Markets Global Healthcare Conference 2026 Transcript
HCA Healthcare, Inc. (HCA) Presents at RBC Capital Markets Global Healthcare Conference 2026 Transcript
Why Investors Need to Take Advantage of These 2 Medical Stocks Now
The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.
HCA Healthcare: Policy Pressures May Be Limiting Admissions (Upgrade)
HCA Healthcare is upgraded to "Hold" after a 12% pullback, and is now trading near fair value with a 7% free cash flow yield. Q1 results were mixed: EPS matched expectations, revenue grew 4%, but surgical volumes softened and margins retraced 50 bps. Policy headwinds, including Medicaid and ACA subsidy rollbacks, are expected to temper growth to 2%-3% annually over the next several years.
HCA Healthcare, Inc. (HCA) Q1 2026 Earnings Call Transcript
HCA Healthcare, Inc. (HCA) Q1 2026 Earnings Call Transcript
HCA Healthcare Q1 Earnings Miss Estimates on Rising Expenses
HCA's Q1 EPS misses estimates as rising expenses and weaker surgeries weigh despite modest revenue growth and gains in ER visits.
HCA (HCA) Reports Q1 Earnings: What Key Metrics Have to Say
While the top- and bottom-line numbers for HCA (HCA) give a sense of how the business performed in the quarter ended March 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
HCA Healthcare (HCA) Q1 Earnings and Revenues Miss Estimates
HCA Healthcare (HCA) came out with quarterly earnings of $7.15 per share, missing the Zacks Consensus Estimate of $7.17 per share. This compares to earnings of $6.45 per share a year ago.
Will Higher Costs & Lower Occupancy Impact HCA's Q1 Earnings?
HCA Healthcare heads into Q1 earnings with higher costs, lower occupancy and shorter stays weighing on results despite revenue growth.
HCA Healthcare's Health Check-Up Reveals Opportunity As Earnings Near
HCA Healthcare has delivered strong multi-year growth in revenue, profits, and cash flow, outperforming the S&P 500 since initial ‘buy' ratings. I maintain a soft ‘buy' on HCA, citing continued operational growth, robust share buybacks, and manageable leverage despite approaching fair value relative to peers. Management projects 2026 revenue of $76.5–$80 billion, EBITDA growth, and ongoing operational improvements, though regulatory and reimbursement risks remain.
Here's Why HCA Healthcare (HCA) is a Strong Value Stock
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
3 Oversold Healthcare Stocks to Buy After Jobs Data
The March jobs report released on April 3 showed an impressive 178,000 jobs were created. Of that number, 76,000 were in the healthcare sector.
